Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication [clinicaltrials:NCT00006578]
Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication [clinicaltrials:NCT00006578]
Bio2RDF identifier
NCT00006578
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00006578
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... beginning anti-HIV treatment.
brief title [clinicaltrials_vocabulary:brief-title]
Evaluation of Specific Infecti ...... and Immune-Boosting Medication
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
In HIV infection, a pro ...... tudy) at participating sites.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-12-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Anti-HIV Agents
Antigens, CD34
Drug Therapy, Combination
Granulocyte Colony-Stimulating Factor
HIV Protease Inhibitors
Lamivudine
Reverse Transcriptase Inhibitors
Stem Cells
Treatment Naive
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-03-05T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00006578
official title [clinicaltrials_vocabulary:official-title]
Evaluation of the Relationship ...... Following G-CSF Administration
org study id [clinicaltrials_vocabulary:org-study-id]
ACTG A5072
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
secondary id [clinicaltrials_vocabulary:secondary-id]
AACTG A5072
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2003-06-01T00:00:00Z
identifier
clinicaltrials:NCT00006578
title
Evaluation of Specific Infecti ...... and Immune-Boosting Medication
@en
type
label
Evaluation of Specific Infecti ...... n [clinicaltrials:NCT00006578]
@en